Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Geranium sibiricum may help manage diabetic complications by inhibiting a key enzyme.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Neurosteroids help protect the brain and improve behavior after a stroke in mice.

Basonuclin 1 (BNC1) helps skin cells multiply and move, which is crucial for wound healing.

Foxn1 helps skin cells mature by controlling a specific protein's activity.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Finasteride worsens heart damage but reduces cell toxicity caused by nandrolone decanoate.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.